Compare Lattice Semiconductor Corporation Common Stock (LSCC) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lattice Semiconductor Corporation Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Lattice Semiconductor Corporation Common Stock trades at $126.05 (market cap $17.76B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: Lattice Semiconductor Corporation Common Stock is far larger — about 7.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is more actively traded (4,179,659 versus 1,802,283). Which is the better fit depends on your goals.
| LSCC | SLS | |
|---|---|---|
Market Cap | $17.76B | $2.27B |
Volume | 1,802,283 | 4,179,659 |
Sector | Technology | Health |
52-Week High | $155.27 | $15.46 |
52-Week Low | $61.73 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $17.62B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Lattice Semiconductor Corporation Common Stock
Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.
Read more on LSCC →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
